IntraLinks Accelerates Drug Funding in the Pipeline for Fast Forward

NEW YORK, NY, Aug 27 (MARKET WIRE) --
IntraLinks(R), the leading provider of critical information exchange
solutions, today announced that Fast Forward(TM) has selected IntraLinks
to help streamline the collection, distribution and tracking of
information to support their funding of multiple biotechnology and
pharmaceutical companies working on new Multiple Sclerosis (MS)
treatments.

"More than two million people around the world live with MS, a chronic and
often debilitating disease. A cure has not yet been discovered. We believe
using IntraLinks facilitates our evaluation and management of the complex
data related to prospective drugs in the development pipeline. This
increases our ability to make funding decisions that will expedite new
treatments to the people who need them," said Maya Merrell, business
manager for Fast Forward.

"IntraLinks simplifies the exchange of information between everyone
involved in our due diligence and funding process -- from board members to
scientific and business advisors and other external constituents. It
streamlines the whole process -- crucial for the small staff at Fast
Forward and its work teams based in different locations," Merrell adds.

"Often times, companies involved in research and technology development
have difficulty securing funds to move scientific ideas from discovery
into preclinical development," said Allison Shurell, vice president of
product marketing for IntraLinks. "We're helping Fast Forward close the
funding gap which had previously slowed the drug development process for
MS."

Fast Forward uses 16 active IntraLinks Exchanges(TM) to manage global
funding opportunities.

About IntraLinks

IntraLinks provides on-demand solutions for businesses to securely
collaborate, communicate and exchange critical information inside and
outside the enterprise. For more than a decade, 750,000 professionals from
more than 90,000 organizations have relied on IntraLinks to accelerate
workflow, optimize business processes and realize new profit potential.
IntraLinks counts 800 of the Fortune 1000 as clients, including
AstraZeneca Pharmaceuticals LP, Bank of America, Deutsche Bank and the
FDIC. For more information, visit www.intralinks.com.

About Fast Forward, LLC

Fast Forward, LLC is a nonprofit organization established by the National
Multiple Sclerosis Society in order to accelerate the development of
treatments for MS. Fast Forward will accomplish its mission by connecting
university-based MS research with private-sector drug development and by
funding small biotechnology/pharmaceutical companies to develop innovative
new MS therapies and repurpose FDA-approved drugs as new treatments for
MS. For more information, visit www.fastforward.org.

CONTACT:

Alison Koski
Text100
212-331-8436
AlisonK@text100.com

Isa Loundon
IntraLinks
212-342-7508
iloundon@intralinks.com

Copyright 2009, Market Wire, All rights reserved.

-0-